Roger's 1997 Short Picks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1997 Short Picks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mama Bear who wrote (7463)	11/23/1997 10:47:00 PM
From: Brad Davies	Read Replies (1) of 9285

Barb, Although I am skeptical about Zona I wouldn't short it yet. The company has about 70M in cash, plus the 10 they just got for selling the marketing rights to Vasomax. They have about 11M shares out for a market cap of about 330M. If they get their FDA approval, it seems to me that they will likely collect on the other 47.5M from Schering, and be entitled to receive the undisclosed royalties. You have to wonder why they would effectively sell the drug to Schering if it was goint to deliver as promised, but it seems to me there are better shorts out there. Just my opinion. Ron

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next